Delivering on what the company calls its vision to “transform care” for the millions currently living with diabetes through intelligent data, Medtronic has just announced new product developments and technology partnerships at the American Diabetes Association (ADA) 76th Scientific Sessions that will create “meaningful insights for providers and people with diabetes.”
New CareLink offerings and advancement of the Medtronic partnership with IBM Watson Health give doctors and their patients “more actionable information, enabling care that is more collaborative, consistent and effective.”
To boot, the company says, the growing network of Medtronic partnerships combines Medtronic diabetes expertise with capabilities expanding data usefulness to provide more holistic diabetes solutions.
“Data, insights and analytics have been a cornerstone for our diabetes strategy with CareLink, and we have accumulated over 125 million patient days of data generated by our devices, including continuous glucose monitoring (CGM) sensor readings and insulin pump events,” said Annette Brüls, president of Diabetes Service and Solutions at Medtronic. “Through our advanced CareLink portfolio and our expanded network of partnerships, we present actionable insights to drive holistic diabetes care solutions that offer greater freedom and better health to people with diabetes.”
To learn more about what Medtronic is up to these days, check out the company online here.